In Switzerland, the mortality rate due to malignant neoplasms among males has shown a slight but consistent upward trend from 9.34 thousand deaths in 2024 to an estimated 9.42 thousand deaths by 2028. The year-on-year increase is notably modest, averaging a growth of approximately 0.21% each year over the five-year forecast period. In 2023, the number of male deaths due to malignant neoplasms stood at 9.32 thousand. The five-year compound annual growth rate (CAGR) from 2024 to 2028 is approximately 0.21%, indicating a slow but steady rise in mortality rates.
Future trends to watch for include potential shifts in healthcare advancements, early detection practices, and changes in lifestyle factors that could influence malignant neoplasms mortality rates. Additionally, demographic changes such as aging population and immigration could also impact these rates. Monitoring healthcare policies, cancer research funding, and public health initiatives will be crucial for understanding and possibly mitigating this upward trend.
